0,948  0,003  TNF expression inhibitor
0,909  0,004  Teratogen
0,907  0,004  Embryotoxic
0,891  0,005  Antiinflammatory
0,857  0,006  CYP3A4 substrate
0,831  0,005  Carcinogenic
0,796  0,007  Antineoplastic (colorectal cancer)
0,794  0,007  Antineoplastic (colon cancer)
0,793  0,010  Antineoplastic (breast cancer)
0,778  0,014  Transcription factor NF kappa B inhibitor
0,766  0,005  Antiallergic
0,752  0,001  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,748  0,003  UGT1A4 substrate
0,730  0,007  Sensitization
0,717  0,004  Hypoxia-inducible factor 1 alpha inhibitor
0,704  0,008  Cholesterol antagonist
0,697  0,003  Antipruritic, allergic
0,703  0,010  Respiratory analeptic
0,716  0,028  Apoptosis agonist
0,670  0,003  Contraceptive
0,674  0,012  Prostate cancer treatment
0,653  0,008  NOS3 expression inhibitor
0,647  0,008  AR expression inhibitor
0,637  0,009  NOS2 expression inhibitor
0,622  0,003  Androgen antagonist
0,621  0,003  Aromatase inhibitor
0,619  0,011  Immunosuppressant
0,618  0,019  CYP2C9 substrate
0,613  0,022  Antileukemic
0,593  0,005  Anesthetic general
0,589  0,003  Contraceptive male
0,595  0,014  Analeptic
0,591  0,013  Proliferative diseases treatment
0,586  0,008  UDP-glucuronosyltransferase substrate
0,574  0,002  Contraceptive female
0,572  0,002  Lipocortins synthesis antagonist
0,577  0,013  UGT1A9 substrate
0,578  0,018  Antineoplastic (ovarian cancer)
0,577  0,017  CYP2C19 substrate
0,562  0,005  Prostatic (benign) hyperplasia treatment
0,569  0,014  Cytostatic
0,567  0,016  Mutagenic
0,562  0,012  Nitric oxide antagonist
0,553  0,005  UGT2B4 substrate
0,560  0,015  Chemopreventive
0,546  0,013  Antineoplastic (glioma)
0,535  0,004  UGT2B7 substrate
0,533  0,002  UGT2B9 substrate
0,530  0,005  Endometrios treatment
0,516  0,002  Antipruritic, non-allergic
0,527  0,018  CYP2C19 inhibitor
0,518  0,012  Antineoplastic (glioblastoma multiforme)
0,507  0,004  Prostate disorders treatment
0,521  0,022  Cytotoxic
0,521  0,024  Antihypercholesterolemic
0,496  0,006  Sulfotransferase substrate
0,494  0,006  Interferon gamma antagonist
0,490  0,004  Antifungal enhancer
0,489  0,004  UGT2B15 substrate
0,476  0,008  Antineoplastic (squamous cell carcinoma)
0,488  0,023  Antineoplastic (pancreatic cancer)
0,465  0,008  Abortion inducer
0,467  0,019  ICAM1 expression inhibitor
0,465  0,017  CYP3A4 inhibitor
0,454  0,007  Sodium/bile acid cotransporter inhibitor
0,470  0,024  Antineoplastic (brain cancer)
0,474  0,049  Antineoplastic (lung cancer)
0,424  0,012  Antineoplastic (carcinoma)
0,419  0,009  Antiacne
0,439  0,033  Antineoplastic (melanoma)
0,425  0,019  Antineoplastic (liver cancer)
0,410  0,009  Antiviral (Influenza)
0,417  0,022  UGT1A6 substrate
0,401  0,007  Antiviral (Influenza A)
0,399  0,011  Hair growth stimulant
0,393  0,006  UGT2B1 substrate
0,384  0,007  Toxic, respiratory center
0,392  0,025  Antineoplastic (renal cancer)
0,447  0,085  Caspase 9 stimulant
0,392  0,046  Immunomodulator
0,392  0,046  Hepatic disorders treatment
0,348  0,003  UGT2B10 substrate
0,363  0,021  UGT1A1 substrate
0,368  0,028  Antimitotic
0,377  0,040  Antineoplastic (cervical cancer)
0,338  0,003  Aldosterone antagonist
0,346  0,020  Skin irritative effect
0,327  0,001  Arachidonic acid antagonist
0,330  0,005  Farnesoid X receptor antagonist
0,336  0,013  Protein kinase stimulant
0,324  0,006  Antiinfertility, female
0,317  0,002  Progesterone agonist
0,367  0,052  CYP2D6 substrate
0,316  0,004  Postmenopausal disorders treatment
0,323  0,015  Allergic rhinitis treatment
0,309  0,003  Progesterone antagonist
0,311  0,013  Antipruritic
0,352  0,055  Apoptosis antagonist
0,317  0,026  P-glycoprotein inhibitor
0,315  0,026  Hepatoprotectant
0,328  0,045  Chronic obstructive pulmonary disease treatment
0,304  0,020  UGT1A3 substrate
0,308  0,028  Eye irritation, high
0,328  0,050  Antineoplastic (multiple myeloma)
0,278  0,002  Glucocorticoid agonist
0,312  0,036  Antineoplastic (sarcoma)
0,328  0,052  Antioxidant
0,340  0,064  Antifungal
0,295  0,023  Diuretic
0,349  0,083  Antiasthmatic
0,284  0,020  NOS3 expression enhancer
0,262  0,004  5-Alpha-reductase inhibitor
0,262  0,004  Androgen agonist
0,378  0,120  Antineoplastic (solid tumors)
0,281  0,024  Anesthetic
0,283  0,029  Antialcoholic
0,317  0,063  Interleukin 2 agonist
0,303  0,051  Cardiodepressant
0,257  0,005  Growth stimulant
0,252  0,002  UGT2B11 substrate
0,256  0,007  Microtubule formation inhibitor
0,275  0,026  Neurotrophic factor enhancer
0,262  0,015  Psychosexual dysfunction treatment
0,250  0,004  Premenstrual syndrome treatment
0,311  0,066  CTGF expression inhibitor
0,347  0,103  Antibacterial
0,261  0,021  Interleukin 6 antagonist
0,290  0,053  Angiogenesis stimulant
0,250  0,014  VEGF expression inhibitor
0,302  0,069  Antineoplastic (osteosarcoma)
0,304  0,071  Antineoplastic (endocrine cancer)
0,237  0,009  Estrogen antagonist
0,230  0,004  Mineralocorticoid receptor antagonist
0,228  0,002  Anabolic
0,250  0,029  Melanin inhibitor
0,318  0,099  Toll-Like receptor 7 agonist
0,236  0,020  Cholesterol synthesis inhibitor
0,227  0,014  Antieczematic
0,215  0,003  RNA-directed RNA polymerase stimulant
0,209  0,002  Postcoital contraceptive
0,224  0,017  Antineoplastic antibiotic
0,308  0,106  Toll-Like receptor agonist
0,204  0,003  Glucocorticoid antagonist
0,237  0,043  Diabetic retinopathy treatment
0,255  0,065  Antineoplastic (lymphoma)
0,259  0,074  Antineoplastic (non-small cell lung cancer)
0,194  0,008  Estrogen agonist
0,260  0,075  DNA damaging
0,254  0,071  Cardiovascular analeptic
0,206  0,026  DNA polymerase I inhibitor
0,197  0,025  Rhinitis treatment
0,191  0,021  SULT1A1 substrate
0,203  0,034  Genotoxic
0,250  0,084  Chemoprotective
0,214  0,050  Muscle relaxant
0,165  0,001  Lipocortins synthesis agonist
0,250  0,091  Antiosteoporotic
0,180  0,021  Alcohol dehydrogenase substrate
0,198  0,047  Antiviral (Herpes)
0,203  0,052  LDLR expression enhancer
0,172  0,025  Menstruation disorders treatment
0,248  0,102  GST M1-1 substrate
0,170  0,025  Choleretic
0,150  0,007  Estrogen receptor beta agonist
0,253  0,111  Bone diseases treatment
0,174  0,033  Glutathione S-transferase substrate
0,145  0,009  Glycine receptor antagonist
0,142  0,007  Anticholelithogenic
0,213  0,079  Antiulcerative
0,141  0,008  Na+ K+ transporting ATPase inhibitor
0,223  0,091  Tumour necrosis factor alpha release inhibitor
0,169  0,037  Alkylator
0,168  0,037  Adenylate cyclase stimulant
0,163  0,034  Pregnane X receptor agonist
0,172  0,043  Neurotrophic factor
0,145  0,017  Estrogen receptor beta antagonist
0,145  0,021  Interleukin 2 antagonist
0,129  0,005  Antitreponemal
0,127  0,006  Estrogen receptor alpha agonist
0,125  0,004  5-Alpha-reductase 2 inhibitor
0,134  0,014  Estrogen receptor alpha antagonist
0,120  0,001  Corticosteroid-like
0,232  0,115  CYP1A2 substrate
0,142  0,027  Breast cancer-resistant protein inhibitor
0,120  0,005  Potassium channel Kv1.3 blocker
0,177  0,063  Antimutagenic
0,179  0,069  Antirickettsial
0,114  0,004  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,217  0,110  Immunostimulant
0,119  0,014  Cushing's syndrome treatment
0,151  0,046  Antihemorrhagic
0,148  0,048  Ca2+-transporting ATPase inhibitor
0,188  0,096  Antiparasitic
0,226  0,136  Caspase 3 stimulant
0,113  0,027  Bile acid receptor antagonist
0,091  0,005  5-Alpha-reductase 1 inhibitor
0,096  0,011  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,087  0,003  Tubulin agonist
0,105  0,021  Narcotic antagonist
0,195  0,112  Antidiabetic symptomatic
0,102  0,020  Glycine receptor agonist
0,111  0,029  Tocolytic
0,085  0,004  Microtubule stabilization
0,115  0,034  SULT1E1 substrate
0,149  0,069  Lipid peroxidase inhibitor
0,114  0,036  Actinic keratosis treatment
0,081  0,005  Hypogonadism treatment
0,089  0,015  SULT2A1 substrate
0,188  0,118  Antipyretic
0,183  0,115  Age-related macular degeneration treatment
0,069  0,005  Glucose-6-phosphate dehydrogenase inhibitor
0,119  0,055  Carcinogenic, group 2B
0,082  0,020  Nitric oxide donor
0,075  0,014  Estradiol 17 beta-dehydrogenase inhibitor
0,112  0,052  Toll-Like receptor 4 antagonist
0,085  0,025  Antiemphysemic
0,137  0,080  Skeletal muscle relaxant
0,155  0,097  Phospholipase C inhibitor
0,107  0,052  Antineoplastic, alkylator
0,075  0,020  Heme oxygenase stimulant
0,058  0,009  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,085  0,039  SULT1A2 substrate
0,095  0,051  Antineoplastic alkaloid
0,072  0,029  Antimycoplasmal
0,073  0,031  Andropause treatment
0,186  0,144  DNA synthesis inhibitor
0,083  0,044  Antibiotic
0,137  0,099  Growth hormone agonist
0,164  0,128  Antiprotozoal (Leishmania)
0,148  0,112  Antihelmintic
0,061  0,028  Pregnane X receptor antagonist
0,087  0,056  Transcription factor NF kappa B stimulant
0,061  0,030  Protein 50S ribosomal subunit inhibitor
0,045  0,016  Cholesterol absorption inhibitor
0,142  0,116  Platelet adhesion inhibitor
0,086  0,062  Interleukin 5 antagonist
0,165  0,142  VCAM1 expression inhibitor
0,025  0,004  Telomerase stimulant
0,021  0,001  Transcortin receptor antagonist
0,169  0,152  Lipoprotein disorders treatment
0,166  0,149  Spasmolytic
0,048  0,032  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,019  0,003  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,133  0,121  Sedative
0,100  0,087  Carcinogenic, group 3
0,151  0,138  Aldehyde oxidase inhibitor
0,173  0,161  Cardioprotectant
0,164  0,154  Interleukin agonist
0,184  0,175  Metabolic disease treatment
0,023  0,014  Estrone sulfatase inhibitor
0,125  0,117  Macular degeneration treatment
0,054  0,046  Acetyl-CoA transferase 2 inhibitor
0,110  0,104  Skin whitener
0,067  0,063  CDC25A inhibitor
0,181  0,178  Gastrin inhibitor
0,026  0,024  Hedgehog signaling activator
0,101  0,100  Tubulin antagonist
0,099  0,099  Aldehyde dehydrogenase inhibitor

